News & Updates

Use of fezolinetant demonstrates efficacy and good tolerability in the treatment of moderate-to-severe vasomotor symptoms associated with menopause in women who are deemed unsuitable for hormone therapy, reports a study.

The overall utilization rates of SGLT2 inhibitors have increased among patients with type 2 diabetes (T2D) following the release of the 2022 American Diabetes Association (ADA) guidelines.

Weight loss interventions help improve some features of polycystic ovary syndrome (PCOS), making it a potential treatment option for women with PCOS, suggests a study.

Hyper- and hypothyroidism are causally associated with pre-eclampsia (PE), but PE does not causally influence thyroid dysfunctions, suggest the results of a Mendelian randomization (MR) study.

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at greater risk of developing incident hepatocellular carcinoma (HCC) when factors such as smoking, alcohol use, obesity, diabetes, and hypertension are present, according to a study. However, use of statin, metformin, or aspirin may modify disease progression.